1,720,970 research outputs found
Integratori e fitoterapici le evidenze in ostetricia e ginecologia
No full textIntegratori e fitoterapici le evidenze in ostetricia e ginecologi
Fitoterapia e integratori in ostetricia e ginecologia
No full textFitoterapia e integratori in ostetricia e ginecologi
Nutrizione e integratori in Ostetricia e Ginecologia
No full textNutrizione e integratori in Ostetricia e Ginecologi
Treatment of hirsutism with myo-inositol: A prospective clinical study
No full textThe aim of this study was to evaluate the effects of myo-inositol treatment in hirsute women; changes in lipid pattern and insulin sensitivity were also considered. Forty-six hirsute women were enrolled at the first Institute of Obstetrics and Gynecology and evaluated at baseline and after receiving myo-inositol therapy for 6 months. Body mass index (BMI), hirsutism, serum concentrations of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, apolipoprotein B, lipoprotein(a), serum adrenal and ovarian androgens, fasting glucose and insulin concentrations were evaluated. No changes in BMI were observed. The hirsutism decreased after therapy (P < 0.001). Total androgens, FSH and LH concentrations decreased while oestradiol concentrations increased. There was a slight non-significant decrease in total cholesterol concentrations, an increase in HDL cholesterol concentrations and a decrease in LDL cholesterol concentrations. No significant changes were observed in serum triglyceride, apolipoprotein B and lipoprotein(a) concentrations. Insulin resistance (P < 0.01), analysed by homeostasis model assessment, was reduced significantly after therapy. Administration of oral myo-inositol significantly reduced hirsutism and hyperandrogenism and ameliorated the abnormal metabolic profile of women with hirsutism. © 2008 Published by Reproductive Healthcare Ltd
Stomatological approach to Sjogren's syndrome: diagnosis, management and therapeutical timing
No full textSjogren's syndrome is a chronic multisystem autoimmune disease characterized by the exocrine glands inflammation, with subsequent hypofunction. More frequently lachrymal and salivary glands are interested with subsequent xerophthalmia and xerostomia. Sjogren's syndrome can be present in an idiopathic type or in association with other autoimmune diseases as rheumatoid arthritis, systemic lupus erythematosus, schlerodermia, etc. It interests mainly the women (with a ratio F:M=9:1) with an age between 40 and 60 years old. The disease prevalence varies from 0.4% to 4.8%. The glandular lesions determine in the time a volume reduction and a secretum quality alteration. The most frequent oral manifestations are xerostomia, that allows the establishment of caries, gingivitises, periodontal disease and oral candidiasis. The aim of this work was to perform a thorough review of the literature on Sjogren's syndrome, illustrating the most internationally accredited diagnostic criteria, the patient's management and therapeutical approach in the odontostomatological discipline. The Authors conclude that it doesn't exist a resolutive treatment of the disease. The therapy is only palliative, and is turned to the treatment of xerostomia and xerophthalmia, through systemic and aspecific sialogogues drugs. From the odontostomatological point of view, particularly useful results the domiciliary and professional oral hygiene to contrast the xerostomia effect on the oral structures
NAUSEA,VOMITING AND THYROID FUNCTION BEFORE AND AFTER INDUCED ABORTION IN NORMAL PREGNANCY.
No full textOdontostomatological approach to the pregnant patient
No full textPregnancy is a condition characterized by various physiological modifications (placentary and ovarian hormones release) that influence various organic districts, including the oral district. In this review were re-examined the rules about the execution of dental services with the relative indications and contraindications during the different phases of pregnancy, the use of the ionizing radiations and the pharmacologic therapy during pregnancy, considering the metabolic, anatomical haemodinamic modifications to which the gestant is exposed during this condition and considering the various parameters related to it: the pharmacokinetic modifications, the drug toxicity based on its teratogenic potential, indications, side effects and specific effects of drugs administrated, the toxicological aspects of dental amalgams and the use of the local anaesthetics during pregnancy. The authors conclude that pregnancy is not a contraindication for the dental treatment and existing an increase of oral diseases, the woman must be exposed to more frequent controls
EFFECTS OF MYO-INOSITOL IN WOMEN WITH PCOS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS.
No full text.
Hereditary haemorragic teleangectasia and pregnancy: Case report
No full textWe report an uncommon case of a 38-years-old pregnant woman affected by HHT (Hereditary haemorrhagic telangiectasia; Osler- Weber-Rendu syndrome) who underwent to a caesarean section (CS) without any complication. The patient at 36th weeks+1 day pregnancy referred to the Emergency Obstetric Unit due to a intercostals pain on left side. On third day after admission the woman started travailing and physicians decided to perform the CS. Considering that no AVMs was found at MRI, a continuous spinal anaesthesia was planned. On postpartum day 4 the patient was discharged. This represents the only case published in the literature. Women with HHT, especially those with arteriovenous malformations (AVM), are at high risk in pregnancy due to physiological haemodynamic changes pregnancy associated. Early screening of patients with HHT for the presence of spinal cord or cerebral AVMs is recommended to optimise perioperative anaesthetic management and to avoid severe complications
- …
